Prosecution Insights
Last updated: October 04, 2026

Meta Therapeutics Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Meta Therapeutics Inc. has 1 pending office action located in the Medical Devices & Mechanical Engineering technology area. The portfolio shows a distribution of work where 1 distinct examiner and 1 distinct art unit oversee the current workload. This arrangement means that the company's immediate patent outcomes are tied to 1 specific regulatory channel within the USPTO. Such a focused approach characterizes the protection of a core innovation within the Medical Devices & Mechanical Engineering field.

The busiest examiner, HOEKSTRA, JEFFREY GERBEN, is responsible for 1 pending office action. Since this 1 pending matter is the total workload currently pending for the company, the examiner's individual throughput and tendencies will define the short-term success of the portfolio. The presence of 1 distinct art unit suggests a technical scope that does not currently cross into multiple engineering disciplines. For the practitioner, this means that the prosecution strategy must be tuned to the specific requirements of 1 distinct examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOEKSTRA, JEFFREY GERBEN 1 56.5% +39.1%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18377313 SMARTWATCH-BASED BODY TEMPERATURE MONITORING SYSTEM AND DISEASE PREDICTION METHOD USING THE SAME HOEKSTRA, JEFFREY GERBEN 1d overdue

Top Art Units

Art UnitApps
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18377313 SMARTWATCH-BASED BODY TEMPERATURE MONITORING SYSTEM AND DISEASE PREDICTION METHOD USING THE SAME HOEKSTRA, JEFFREY GERBEN 3791 §102 Final Rejection 1d overdue Pending Oct 06, 2023

Managing Meta Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month